Related Experiment Video
Updated: Apr 27, 2026

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
Published on: September 12, 2016
Minimal supportive treatment in natalizumab-related PML in a MS patient
Patrice H Lalive1, Claire Bridel2, Ruxandra Iancu Ferfoglia2
1Unit of Neuroimmunology and Multiple Sclerosis, Division of Neurology, Department of Clinical Neurosciences, Geneva University Hospital and Faculty of Medicine of the University of Geneva, Geneva, Switzerland Division of Laboratory Medicine, Department of Genetic and Laboratory Medicine, Geneva University Hospital, Geneva, Switzerland.
No abstract available in PubMed .
Related Concept Videos
Multiple Sclerosis l: Introduction
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Alzheimer's Disease: Treatment
Antiepileptic Drugs: Glutamate Antagonists
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Angle Closure Glaucoma: Treatment

